Submitted by Anonymous (not verified) on 20 November 2023 - 13:36
Human medicines European public assessment report (EPAR): Spectrila, asparaginase, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Date of authorisation: 14/01/2016, Revision: 6, Status: Authorised
Source: